Literature DB >> 8962059

Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa.

C D Dickinson1, C R Kelly, W Ruf.   

Abstract

Factor VIIa (VIIa), the serine protease that initiates the coagulation pathways, is catalytically activated upon binding to its cell surface receptor and cofactor tissue factor (TF). This study provides a comprehensive analysis of the functional surface of VIIa by alanine scanning mutagenesis of 112 residues. Residue side chains were defined which contribute to TF binding and factor X hydrolysis. Energetically important binding contacts at the interface with TF were identified in the first epidermal growth factor domain of VIIa (Gln-64, Ile-69, Phe-71, Arg-79) and in the protease domain (Arg-277, Met-306, Asp-309). The observed energetic defects are in good agreement with the corresponding residues in TF, suggesting that the VIIa light chain plays a prominent role in high affinity binding of cofactor. Mutation of protease domain interface residues indicated that TF allosterically influences the active site of VIIa. Stabilization of a labile zymogen to enzyme transition could explain the activating effect of TF on VIIa catalytic function. Residues important for factor X hydrolysis were found in three regions of the protease domain: (i) specificity determinants in the catalytic cleft and adjacent loops, (ii) an exosite near the TF binding site, and (iii) a large electronegative exosite which is in a position analogous to the basic exosite I of thrombin. TF regions involved in factor X activation are positioned on the same face of the TF-VIIa complex as the two exosites identified on the protease domain surface, providing evidence for an extended interaction of TF-VIIa with macromolecular substrate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8962059      PMCID: PMC26140          DOI: 10.1073/pnas.93.25.14379

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Additivity of mutational effects in proteins.

Authors:  J A Wells
Journal:  Biochemistry       Date:  1990-09-18       Impact factor: 3.162

2.  Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male.

Authors:  D P O'Brien; K M Gale; J S Anderson; J H McVey; G J Miller; T W Meade; E G Tuddenham
Journal:  Blood       Date:  1991-07-01       Impact factor: 22.113

3.  Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-A resolution.

Authors:  M A Navia; B M McKeever; J P Springer; T Y Lin; H R Williams; E M Fluder; C P Dorn; K Hoogsteen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

4.  Refined crystal structure of Streptomyces griseus trypsin at 1.7 A resolution.

Authors:  R J Read; M N James
Journal:  J Mol Biol       Date:  1988-04-05       Impact factor: 5.469

5.  Three-dimensional structure of the complex between pancreatic secretory trypsin inhibitor (Kazal type) and trypsinogen at 1.8 A resolution. Structure solution, crystallographic refinement and preliminary structural interpretation.

Authors:  M Bolognesi; G Gatti; E Menagatti; M Guarneri; M Marquart; E Papamokos; R Huber
Journal:  J Mol Biol       Date:  1982-12-25       Impact factor: 5.469

6.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

7.  1.9-A structures of ternary complexes of citrate synthase with D- and L-malate: mechanistic implications.

Authors:  M Karpusas; D Holland; S J Remington
Journal:  Biochemistry       Date:  1991-06-18       Impact factor: 3.162

8.  Role of the activation peptide domain in human factor X activation by the extrinsic Xase complex.

Authors:  R J Baugh; S Krishnaswamy
Journal:  J Biol Chem       Date:  1996-07-05       Impact factor: 5.157

9.  Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function.

Authors:  W Ruf; A Rehemtulla; J H Morrissey; T S Edgington
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

10.  The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment.

Authors:  W Bode; I Mayr; U Baumann; R Huber; S R Stone; J Hofsteenge
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

View more
  40 in total

1.  Probing the structural changes in the light chain of human coagulation factor VIIa due to tissue factor association.

Authors:  L Perera; T A Darden; L G Pedersen
Journal:  Biophys J       Date:  1999-07       Impact factor: 4.033

2.  Structure of human factor VIIa and its implications for the triggering of blood coagulation.

Authors:  A C Pike; A M Brzozowski; S M Roberts; O H Olsen; E Persson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

3.  Identification of exosite residues of factor Xa involved in recognition of PAR-2 on endothelial cells.

Authors:  Chandrashekhara Manithody; Likui Yang; Alireza R Rezaie
Journal:  Biochemistry       Date:  2012-03-15       Impact factor: 3.162

Review 4.  Protease signalling: the cutting edge.

Authors:  Boris Turk; Dušan Turk; Vito Turk
Journal:  EMBO J       Date:  2012-02-24       Impact factor: 11.598

5.  Antibody-induced enhancement of factor VIIa activity through distinct allosteric pathways.

Authors:  Lisbeth M Andersen; Peter A Andreasen; Ivan Svendsen; Janneke Keemink; Henrik Østergaard; Egon Persson
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

6.  Mutagenesis-based definitions and probes of residue burial in proteins.

Authors:  Kanika Bajaj; Purbani Chakrabarti; Raghavan Varadarajan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-26       Impact factor: 11.205

7.  Why Ser and not Thr brokers catalysis in the trypsin fold.

Authors:  Leslie A Pelc; Zhiwei Chen; David W Gohara; Austin D Vogt; Nicola Pozzi; Enrico Di Cera
Journal:  Biochemistry       Date:  2015-02-11       Impact factor: 3.162

8.  Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON.

Authors:  Zhiwei Hu; Rulong Shen; Amanda Campbell; Elizabeth McMichael; Lianbo Yu; Bhuvaneswari Ramaswamy; Cheryl A London; Tian Xu; William E Carson
Journal:  Cancer Immunol Res       Date:  2018-04-05       Impact factor: 11.151

9.  Augmented intrinsic activity of Factor VIIa by replacement of residues 305, 314, 337 and 374: evidence of two unique mutational mechanisms of activity enhancement.

Authors:  Egon Persson; Helle Bak; Anette Østergaard; Ole H Olsen
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

10.  Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice.

Authors:  Zhiwei Hu; Benqiang Rao; Shimin Chen; Jinzhong Duanmu
Journal:  BMC Cancer       Date:  2010-05-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.